Nu Skin To Use Helix BioMedix Technology
BOTHELL, Wash.--Helix BioMedix Inc., an early-stage biotechnology company, entered into a developmental agreement with Nu Skin International Inc. (www.nuskinusa.com) to explore the use of Helix BioMedix peptide in a new acne treatment from Nu Skin. Under terms of the agreement, Helix BioMedix (www.helixbiomedix.com) will receive a technology access fee and royalties based on the peptide's performance. The companies are currently exploring opportunities for a broader licensing agreement.